Showing 1 to 7 of 7 results
Shingles Vaccine Linked to Reduced Risk of Heart Attack and Stroke
A new study funded by GSK, the manufacturer of a shingles vaccine, found that adults who received the shingles vaccine had an 18% lower risk of major cardiac events, with a 16% reduction among those over 50; however, the study's observational nature prevents establishing direct causality.
Shingles Vaccine Linked to Reduced Risk of Heart Attack and Stroke
A new study funded by GSK, the manufacturer of a shingles vaccine, found that adults who received the shingles vaccine had an 18% lower risk of major cardiac events, with a 16% reduction among those over 50; however, the study's observational nature prevents establishing direct causality.
Progress
24% Bias Score
Shingles Vaccine Linked to 23% Lower Cardiovascular Disease Risk
A South Korean study of over 1.2 million people found that the shingles vaccine reduced the risk of cardiovascular disease by 23%, particularly within eight years of vaccination and even among those with unhealthy lifestyles, suggesting a broader role for vaccination in long-term health.
Shingles Vaccine Linked to 23% Lower Cardiovascular Disease Risk
A South Korean study of over 1.2 million people found that the shingles vaccine reduced the risk of cardiovascular disease by 23%, particularly within eight years of vaccination and even among those with unhealthy lifestyles, suggesting a broader role for vaccination in long-term health.
Progress
28% Bias Score
Shingles Vaccine Linked to 20% Lower Dementia Risk in Large Study
A study of nearly 300,000 Welsh people revealed a 20% lower dementia risk among those vaccinated against shingles, possibly offering a cost-effective preventative measure, and prompting discussions around broader vaccine implementation.
Shingles Vaccine Linked to 20% Lower Dementia Risk in Large Study
A study of nearly 300,000 Welsh people revealed a 20% lower dementia risk among those vaccinated against shingles, possibly offering a cost-effective preventative measure, and prompting discussions around broader vaccine implementation.
Progress
48% Bias Score
Shingles Vaccine Shows Promise in Reducing Dementia Risk for Women
A British study published in Nature revealed that the Zostavax shingles vaccine reduced dementia risk by 20% in women over seven years in Wales, suggesting a link between varicella-zoster virus and dementia; further research is needed to clarify the underlying mechanisms and sex-specific effects.
Shingles Vaccine Shows Promise in Reducing Dementia Risk for Women
A British study published in Nature revealed that the Zostavax shingles vaccine reduced dementia risk by 20% in women over seven years in Wales, suggesting a link between varicella-zoster virus and dementia; further research is needed to clarify the underlying mechanisms and sex-specific effects.
Progress
52% Bias Score
Shingles Vaccine Linked to Reduced Heart Disease Risk in Large Study
A South Korean study of over 1.2 million people aged 50+ revealed a 23% lower risk of heart disease in those who received the shingles vaccine, with benefits exceeding expectations, particularly in men under 60 and those with unhealthy lifestyles; further research is needed to confirm these findings...
Shingles Vaccine Linked to Reduced Heart Disease Risk in Large Study
A South Korean study of over 1.2 million people aged 50+ revealed a 23% lower risk of heart disease in those who received the shingles vaccine, with benefits exceeding expectations, particularly in men under 60 and those with unhealthy lifestyles; further research is needed to confirm these findings...
Progress
40% Bias Score
Shingles Vaccine Linked to Lower Dementia Risk
A Welsh study published in Nature found a 3.5% lower dementia risk in individuals who received the shingles vaccine compared to those who didn't, suggesting that viral infections might play a more significant role in dementia than previously thought.
Shingles Vaccine Linked to Lower Dementia Risk
A Welsh study published in Nature found a 3.5% lower dementia risk in individuals who received the shingles vaccine compared to those who didn't, suggesting that viral infections might play a more significant role in dementia than previously thought.
Progress
52% Bias Score
Shingles Vaccine Linked to 20% Lower Dementia Risk in Welsh Study
A study of 280,000 Welsh adults revealed a 20% lower dementia risk among Zostavax recipients over seven years, particularly women, suggesting a broader health benefit beyond shingles prevention.
Shingles Vaccine Linked to 20% Lower Dementia Risk in Welsh Study
A study of 280,000 Welsh adults revealed a 20% lower dementia risk among Zostavax recipients over seven years, particularly women, suggesting a broader health benefit beyond shingles prevention.
Progress
28% Bias Score
Showing 1 to 7 of 7 results